“With her years of experience and success as both an operating leader and investor in medical device start-up companies like NxThera, Jan Garfinkle has a deep understanding of what it takes to build a successful business. When the inevitable challenges arise at NxThera, Jan’s knowledge and experience, together with her thoughtful and disciplined approach, helps us in developing and implementing practical and effective solutions. I appreciate the fact that Jan consistently challenges me to think ‘big’ and know that I have the support necessary to help us achieve our goals.”
Bob Paulson
CEO
NXThera
Jan Garfinkle
 |
Jan Garfinkle, Founder and Managing DirectorJan Garfinkle specializes in medical technology investments, utilizing her educational background in biomedical engineering, extensive operating experience, and industry connections to select and nurture outstanding companies. Her investing activities primarily focus on FDA 510(k) and PMA medical device and diagnostics companies. Jan has been a member of the board of directors of Arboretum portfolio companies including HandyLab (acquired by Becton, Dickinson and Company), NXThera, Uptake Medical, and VasoNova.
Prior to founding Arboretum in 2002, Jan spent 20 years in senior management positions in entrepreneurial healthcare companies. Jan was Founder and President of Strategic Marketing Consultants, a consulting firm focused on the commercialization of healthcare technologies for start-ups and large medical device manufacturers. Earlier in her career, Jan worked for two successful medical device start-up companies, Advanced Cardiovascular Systems (ACS) and Devices for Vascular Intervention (DVI). Each of these companies was acquired by Eli Lilly and Company for more than $100 million and became the foundation for Guidant Corporation, which Eli Lilly later spun out in 1994. She joined each company early in its development and held key management roles in marketing, clinical research and sales. She began her career as a manufacturing engineer and production line manager for Proctor and Gamble.
Jan has served on a number of advisory boards focused on capital formation and enhancing the commercialization of promising technologies. She is the past President of the Michigan Venture Capital Association. She is a member of the Commercialization Advisory Board of the Global Cardiovascular Innovation Center (GCIC) at the Cleveland Clinic and a member of the Health Care Advisory Board at the University of Michigan. Jan also serves as a member of AdvaMed’s National Venture Capital Advisory Board. Jan earned a BS in Bioengineering from the University of California at Berkeley and an MBA from the Wharton School at the University of Pennsylvania.
|
